Intravenous stem cell transplantation
201400000003-2
Phase 1 gene_therapy active
Quick answer
Intravenous stem cell transplantation for Stroke is a Phase 1 program (gene_therapy) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Stroke
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- active